Cardiol Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.322; its P/E ratio is -5.33; Cardiol Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	C$ -7.64M	C$ -5.93M	C$ -7.47M	C$ -7.09M	C$ -8.10M
EBITDA	C$ -7.57M	C$ -5.87M	C$ -7.41M	C$ -7.03M	-
Net Income Common Stockholders	C$ -7.64M	C$ -5.93M	C$ -7.47M	C$ -7.09M	C$ -7.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 34.93M	C$ 40.54M	C$ 44.94M	C$ 49.47M	C$ 59.47M
Total Assets	C$ 36.70M	C$ 43.05M	C$ 47.17M	C$ 52.69M	C$ 62.03M
Total Debt	C$ 174.34K	C$ 181.21K	C$ 48.19K	C$ 60.66K	C$ 72.87K
Net Debt	C$ -34.76M	C$ -40.36M	C$ -44.89M	C$ -49.41M	C$ -59.40M
Total Liabilities	C$ 8.45M	C$ 8.18M	C$ 8.42M	C$ 7.13M	C$ 9.83M
Stockholders Equity	C$ 28.25M	C$ 34.87M	C$ 38.75M	C$ 45.56M	C$ 52.20M
Cash Flow	-
Free Cash Flow	-	C$ -3.42M	C$ -5.36M	C$ -9.99M	C$ -8.97M
Operating Cash Flow	C$ -6.46M	C$ -3.41M	C$ -5.35M	C$ -9.95M	C$ -8.92M
Investing Cash Flow	C$ -10.71K	C$ -5.58K	C$ -3.89K	C$ -44.14K	C$ -47.83K
Financing Cash Flow	C$ -13.84K	C$ -13.84K	C$ -13.84K	C$ -13.84K	C$ -13.84K

Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Income Statement >

Cardiol Therapeutics Debt to Assets

Balance Sheet >

Cardiol Therapeutics Cash Flow

Cash Flow >

Cardiol Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing